Parabilis Medicines, Inc. 4

Craig Tendler received a compensatory stock option award for 20,294 shares of Parabilis Medicines, Inc. common stock at a $39.36 exercise price.

On August 22, 2026, reporting person Craig Tendler received a stock option award from Parabilis Medicines, Inc. for 20,294 shares of common stock at an exercise price of $39.36 per share, recorded with a deemed transaction price of $0.00 as it is a compensatory grant rather than an open-market trade. The option is scheduled to vest in thirty-six equal monthly installments beginning August 22, 2026 and continuing through August 21, 2036, contingent on his continued service with the company. Following this grant, Tendler holds 20,294 derivative securities (options) representing the right to acquire an equivalent number of common shares, although the filing does not provide a current market price to estimate the total value of the award or his post-grant holdings.

Filing Facts

CIK

1657677

Ticker

PBLS

Form

4

Source Type

fda

Accession

0001193125-26-365484

Alert Tier

5